An observational study in Transgenderism, Insulin Sensitivity/Resistance and Endothelial Dysfunction, sponsored by University of Colorado, Denver. Recruiting at 1 site in United States. Open to male participants aged 9 Years to 14 Years. Per ClinicalTrials.gov, last updated 2025-06-10.
Sponsored by University of Colorado, Denver · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This observational study will evaluate the effect of puberty suppression on insulin sensitivity, metabolic rate and vascular health among transgender female youth at baseline and 6 months after initiation of a gondoatropin releasing hormone agonist compared to matched cisgender male controls.
54 studies on the registry are indexed under Transsexualism; 18 are open to participants now.
This study's planned enrollment of 30 is below the median of 100 across 28 observational studies indexed under Transsexualism.
Browse Transsexualism studies →University of Colorado, Denver is the lead sponsor of 1,547 studies on the registry; 318 are open to participants now.
Of its 148 completed or terminated interventional studies of FDA-regulated products, 93 (63%) have results posted.
Compared within Transsexualism, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →
15 transgender females (male sex assigned at birth, female gender identity) and 15 cisgender males
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Transgender females who plan to start a gonadotropin releasing hormone agonist clinically in the next 2 months
Cisgender male controls
Change in insulin sensitivity
Insulin sensitivity assessed by the oral minimal model
Time frame: Baseline, 6 months
Change in body composition (fat mass, fat-free mass)
Body composition measured by DXA
Time frame: Baseline, 6 months
Change in resting metabolic rate
Resting metabolic rate assessed by indirect calorimetry
Time frame: Baseline, 6 months
Change in endothelial function
Endothelial function assessed by brachial artery flow mediated dilation
Time frame: Baseline, 6 months
Change in large elastic artery stiffness
Large elastic assessed by carotid ultrasound
Time frame: Baseline, 6 months
Change in cerebrovascular function
Middle cerebral artery blood flow assessed using bilateral transcranial Doppler
Time frame: Baseline, 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
Started Aug 2020 (actual). Primary completion is estimated for Jul 2026, 71 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Colorado, Denver →